QuickView for brentuximab vedotin (compound)

Genetic Markers

Most Correlated Genes

1. No genes found

Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

1. No biogroups found

Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

No studies found

Explore Curated Studies Results

Literature

Most Relevant Literature

1. Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failu…
2. Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or…
3. Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.
4. Cost-effectiveness of brentuximab vedotin for relapsed or refractory systemic anaplastic large-cell …
5. Management of mycosis fungoide : focus on brentuximab vedotin].

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

1. Brentuximab Vedotin for Systemic Sclerosis
2. A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin S…
3. Brentuximab Vedotin for Steroid Refractory GvHD
4. Brentuximab Vedotin + Re-induction Chemotherapy for AML
5. A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Explore Clinical Trials Results

search → result

search → result